Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning (Q34197491)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Paolo Corradini

object named as

P Corradini

5

0 references

author name string

P Dreger

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Brand

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Hansz

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Milligan

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J Finke

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

G L Deliliers

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Martino

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

N Russell

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A Van Biezen

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Michallet

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Niederwieser

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chronic Leukemia Working Party of the EBMT

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

841-848

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

21 January 2018

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402905

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402905

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34197491&oldid=2196371256"